Efficacy of the fixed-dose combination of valsartan 160/HCTZ 25 in hypertensive patients not controlled by the combination of candesartan 32/HCTZ 25 - The Cicero trial

被引：0

作者：

Schweizer, J.

Hilsmann, U.

Neumann, G.

Handrock, R.

Klebs, S.

机构：

[1] Chemnitz Hosp, Chemnitz, Germany

[2] Practice Internal Med, Dortmund, Germany

[3] Practice Internal Med, Delitzsch, Germany

[4] Novartis Pharma GmbH, Nurnberg, Germany

来源：

JOURNAL OF HYPERTENSION | 2007年 / 25卷

关键词：

D O I：

暂无

中图分类号：

R6 [外科学];

学科分类号：

1002 ; 100210 ;

摘要：

引用

页码：S228 / S228

页数：1

共 50 条

[1] Efficacy and safety of valsartan 160/HCTZ 25 mg in fixed combination in hypertensive patients not controlled by candesartan 32 mg plus HCTZ 25 mg in free combination
Schweizer, J.
Hilsmann, U.
Neumann, G.
Handrock, R.
Klebs, S.
CURRENT MEDICAL RESEARCH AND OPINION, 2007, 23 (11) : 2877 - 2885
[2] The fixed dose combination of valsartan 160/HCTZ 25 in hypertensive patients not controlled by fixed dose combinations of at 1 receptor antagonists and low dose HCTZ
Fuenfstueck, R
Hempel, RD
Ansari, A
Weidinger, G
Klebs, S
JOURNAL OF HYPERTENSION, 2005, 23 : S379 - S380
[3] The fixed dose combination of valsartan 160/HCTZ 25 in hypertensive patients not controlled by fixed dose combinations of AT1 receptor antagonists and low dose HCTZ
Fuenfstueck, R
Hempel, RD
Ansari, A
Weidinger, G
Klebs, S
AMERICAN JOURNAL OF HYPERTENSION, 2005, 18 (05) : 59A - 59A
[4] EFFICACY OF THE SINGLE-PILL COMBINATION OF ALISKIREN 300/HCTZ 25 (+/- AMLODIPINE 5) IN HYPERTENSIVE PATIENTS NOT CONTROLLED BY THE COMBINATION OF CANDESARTAN 32/HCTZ 25
Schweizer, J.
Klebs, S.
JOURNAL OF HYPERTENSION, 2010, 28 : E474 - E474
[5] The fixed dose combination of valsartan 160/HCTZ 25 in hypertensive patients not controlled by monotherapy with olmesartan 40 or olmesartan 20 plus HCTZ 12.5
Trenkwalder, P
Samer, H
Hempel, RD
Weidinger, G
Klebs, S
JOURNAL OF HYPERTENSION, 2005, 23 : S122 - S122
[6] Fixed dose combination of valsartan 160/HCTZ 25 in hypertensive patients not controlled by monotherapy with olmesartan 40 or olmesartan 20 plus HCTZ 12.5
Trenkwalder, P.
Samer, H.
Hempel, R. -D.
Weidinger, G.
Klebs, S.
JOURNAL OF HYPERTENSION, 2006, 24 : 316 - 316
[7] Valsartan 160/HCTZ 25 effectively reduces blood pressure in hypertensive patients not controlled by valsartan 160/HCTZ 12.5
Trenkwalder, P
Ulmer, HJ
Wolf, H
Handrock, R
JOURNAL OF HYPERTENSION, 2004, 22 : S391 - S391
[8] Valsartan 160/HCTZ 25 effectively reduces blood pressure in hypertensive patients not controlled by valsartan 160/HCTZ 12.5
Trenkwalder, P
Ulmer, HJ
Wolf, H
Handrock, R
JOURNAL OF HYPERTENSION, 2004, 22 : S194 - S194
[9] The fixed dose combination of valsartan 16o/HCTZ 25 in hypertensive patients not controlled by high dose monotherapy of an angiotensin receptor blocker or combination therapy with HCTZ 12.5
Trenkwalder, P
Simer, H
Hempel, RD
Weidinger, G
Klebs, S
MEDIZINISCHE KLINIK, 2006, 101 (04) : A51 - A51
[10] Efficacy and tolerability of HCTZ 25 mg in combination with valsartan 160 mg in hypertensive patients not adequately controlled with a combination of high doses of ARBs and HCTZ 12,5 mg
Girerd, X
Denolle, T
Brunel, P
Yau, C
Fiquet, B
Moulin, B
Herpin, D
AMERICAN JOURNAL OF HYPERTENSION, 2004, 17 (05) : 107A - 108A

← 1 2 3 4 5 →